Antares Pharma (ATRS +2.6%) has amended its agreement with Hercules Capital increasing its term loan limit by $25M to $50M. It drew $15M when the contract was signed and can draw up to an additional $10M effective January 1, 2020 (through September 15, 2020). It borrowed the initial $25M in June 2017.
Concurrently, it has canceled its at-the-market equity financing deal effective July 6. It has not sold any shares under the facility since March 31.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.